Medin drives Aβ40 to adopt Aβ42-like fibril polymorphs in vitro

Brajabandhu Pradhan1,2, Senthil T Kumar1,2, Jessica Wagner3

  • 1Switch Laboratory, VIB Center for Brain and Disease Research, 3000 Leuven, Belgium.

Insights

Medin protein accelerates amyloid-beta 40 (Aβ40) aggregation and forms hybrid fibrils. This interaction creates new Aβ40 fibril structures, revealing insights into amyloid polymorphism in diseases like Alzheimer's.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Medin is a prevalent localized human amyloid co-localizing with amyloid-beta (Aβ) in Alzheimer's disease and cerebral amyloid angiopathy (CAA).
  • Medin is known to promote Aβ aggregation, but its effect on the resulting fibril structure is unclear.

Purpose of the Study:

  • To investigate how medin modulates Aβ40 fibril assembly and structure in vitro.
  • To elucidate the structural consequences of medin-Aβ40 heterotypic co-aggregation.

Main Methods:

  • In vitro studies using cryo-electron microscopy (cryo-EM).
  • Aggregation kinetics assays.
  • Immunogold electron microscopy.

Main Results:

  • Medin accelerates Aβ40 aggregation and forms hybrid fibrils with altered morphology.
  • Cryo-EM revealed two Aβ40 fibril populations: a known polymorph and a novel one with Aβ42-like features.
  • The new polymorph exhibits a structured N-terminus and compact C-terminal core, stabilized by heterotypic interactions.

Conclusions:

  • Heterotypic co-aggregation of medin and Aβ40 redirects Aβ40 into distinct conformational states.
  • Dynamic or transient interactions contribute to fibril polymorphism, influencing structures beyond static models.
  • Findings offer structural insights into amyloid interactions in neurodegenerative diseases.